Howard Hughes Medical Institute’s Lam Research LRCX Stock Holding History

Howard Hughes Medical Institute’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.72M	Buy	17,396 +17,126	+6,343%	+$3.83M	0.89%	18
2025 Q4	$46.2K	Sell	270 -2	-0.7%	-$311	0.03%	45
2025 Q3	$36.4K	Sell	272 -5	-2%	-$529	0.02%	58
2025 Q2	$27K	Buy	+277	New	+$22K	0.01%	85
2015 Q4	–	Sell	-86,910	Closed	-$568K	–	181
2015 Q3	$568K	Buy	86,910 +7,790	+10%	+$57.1K	0.11%	89
2015 Q2	$644K	Sell	79,120 -44,660	-36%	-$351K	0.14%	89
2015 Q1	$869K	Buy	123,780 +22,370	+22%	+$177K	0.12%	75
2014 Q4	$805K	Buy	101,410 +36,250	+56%	+$281K	0.22%	67
2014 Q3	$487K	Buy	65,160 +49,190	+308%	+$351K	0.11%	79
2014 Q2	$108K	Buy	+15,970	New	+$95.4K	0.02%	119

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Hughes Medical Institute's LRCX Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Lam Research (LRCX) stake by 6,343% in Q1 2026, buying an estimated $3.83M and bringing the position to 17,396 shares worth $3.72M. The position accounts for 0.89% of the portfolio, ranked #18.

Howard Hughes Medical Institute first reported a position in LRCX in Q2 2014 and has held it in 10 quarters since. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Howard Hughes Medical Institute held 17,396 shares of Lam Research worth $3.72M as of Q1 2026.
Howard Hughes Medical Institute bought 17,126 Lam Research shares in Q1 2026, an estimated $3.83M.
Lam Research made up 0.89% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #18 holding.
Howard Hughes Medical Institute first reported a position in Lam Research in Q2 2014 and has held it in 10 quarters since.
2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.